Patients with IBD had a higher incidence of melanoma than controls; this association was significant in patients with Crohn disease (incidence rate ratio, 1.45) but not in patients with UC (IRR, 1.13). Researchers observed a trend of increasing risk for melanoma in patients with IBD over time. In a nested case-control analysis, any use of a biologic anti–tumor necrosis factor (anti-TNF) agent was associated with an almost twofold increased risk for melanoma, unlike thiopurines or 5-aminosalicylic acid (5-ASA) medications, for which no associations were observed. The risk for NMSC was increased by almost twofold in patients who used any thiopurine, but was not significantly increased in patients who used anti-TNF agents.Makes sense that there are side-effects of using biologics.
Tuesday, August 28, 2012
Biologics for Inflammatory Bowel Disease Increase Risk for Melanoma
Monday, January 16, 2012
IBD Less Common in Sunny States
"A leading explanation for this north-south gradient in the risk of ulcerative colitis and Crohn's disease may be differences in exposure to sunlight, or UVB radiation, which is generally greater in southern latitudes," wrote Dr. Hamed Khalili, of Massachusetts General Hospital in Boston, and colleagues.
"UV radiation is the greatest environmental determinant of plasma vitamin D, and there is substantial experimental data supporting a role for vitamin D in the innate immunity and regulation of inflammatory response," they noted.
Sunday, November 13, 2011
Could Sucralose (Splenda) Be A Contributor?
Saw an interesting article that suggested that Splenda (sucralose) was potentially to blame for the rapid rise in IBD in Canada.The theory that Splenda may be a culprit in the rise of inflammatory bowel disease (IBD) appears to be a reasonable one, echoing the results from a 2008 study published in the Journal of Toxicology and Environmental Health, which discovered that Splenda:
- Increases the pH level in your intestines, and
- Reduces the amount of good bacteria in your intestines by 50 percent!
Bilberries May Help Control IBD
Bilberries (or huckleberries) may help control symptoms of inflammatory bowel disease. Researchers in Europe suggest positive results (see article) from a study of colitis in mice. Blueberries are a close relative to bilberries, so they might serve as a more accessible alternative.Bilberries, which are a close relative to blueberries, contain anthocyanins, pigments that have antioxidant, anticancer, and anti-inflammatory properties. Previous studies show bilberries are effective in the management of diarrhea, which is one of the main characteristics of inflammatory bowel disease.
Crohn's Disease Genes Linked to Multiple Illnesses
The study by the University of Edinburgh has found that genes responsible for Crohn’s disease are linked with other conditions including breast and prostate cancer, Hodgkin’s lymphoma, high cholesterol and obesity.
Knowing how diseases are genetically connected could aid efforts to develop medicines and potential side-effects could be predicted and avoided.
Tuesday, November 8, 2011
The Low FODMAP Diet
The theory is that many people with IBS have trouble absorbing certain carbohydrates in their small intestines. Large molecules of those foods travel to the colon, where they are attacked by bacteria and ferment, creating the telltale IBS symptoms of gas, bloating, constipation or diarrhea.
A long list of foods—including dairy products, some fruits and vegetables, wheat, rye, corn syrup and artificial sweeteners—can potentially create such problems in susceptible people. Collectively, they're known as Fodmaps, an acronym that for stands for Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.
Monday, August 15, 2011
Crohn's Disease, the Rise of Agriculture, and Gene Expression
Just read a really complicated article that went way over my head in Discover Magazine, but thought I'd share it as there are some interesting theories presented.
So what happened? The authors posit that the 503F allele was selectively favored at some point in the past, and flanking it were the Crohn’s disease risk elevating variants of IRF1 and IL5. All things equal it is best not to have a risk for this disease, but all things are not equal. If there was a strong enough selective pressure on the target, 503F, then the downsides of the fact that it came as a “total package” with some deleterious alleles would be irrelevant. Over a long enough evolutionary time the deleterious alleles would be purified through negative selection because recombination does break apart associations, but there’s a lot of reality which consists of being between beginnings and ends.
